ArticleMolecular cancer2014

Genetic targeting of B-RafV600E affects survival and proliferation and identifies selective agents against BRAF-mutant colorectal cancer cells.

Benjamin Hirschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.